Catalysts

Zacks Small Cap Research – LGMK: Potential Revenue Catalysts: GSA Approval, Medicaid Waivers, Device Upgrades – Go Health Pro

by
Zacks Small Cap Research – LGMK: Potential Revenue Catalysts: GSA Approval, Medicaid Waivers, Device Upgrades – Go Health Pro

By M. Marin NASDAQ:LGMK READ THE FULL LGMK RESEARCH REPORT Recent introduction of next-gen Guardian Alert 911 Plus in 1Q25… LogicMark, Inc. (NASDAQ:LGMK) launched the next generation of the Guardian Alert 911 Plus in February 2025. The next-generation Guardian Alert 911 Plus expands the company’s product suite and offers an upgrade from the earlier version … Read more

Zacks Small Cap Research – ARWR: Multiple Catalysts Ahead in 2025… – Go Health Pro

by

By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Plozasiran Update On January 17, 2025, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for plozasiran for the treatment of familial chylomycronemia syndrome (FCS), with a Prescription Drug User Fee Act … Read more

Zacks Small Cap Research – SWP.TO: Industry Outlook Shows Expected Catalysts for Swiss Water Growth Continuing – Go Health Pro

by
Zacks Small Cap Research – SWP.TO: Industry Outlook Shows Expected Catalysts for Swiss Water Growth Continuing – Go Health Pro

By M. Marin OTC:SWSSF | TSX:SWP.TO READ THE FULL SWP.TO RESEARCH REPORT Rising consumption of ‘decaf’ & specialty coffees important are growth drivers that are expected to continue… British Columbia-based Swiss Water Decaffeinated Coffee Inc. (OTC:SWSSF) (TSX:SWP.TO) is a leading specialty coffee company and premium green coffee decaffeinator focused on producing chemical-free decaffeinated coffee. The … Read more